 | • レポートコード：QAF27609 • 出版社/出版日：QYResearch / 2021年3月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のセファロスポリン市場について種類別（第1世代セファロスポリン、第2世代セファロスポリン、第3世代セファロスポリン、第4世代セファロスポリン）、用途別（経口、注射）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・セファロスポリン市場の概要 ・世界の主要地域別セファロスポリン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のセファロスポリン市場規模2016-2021：種類別（第1世代セファロスポリン、第2世代セファロスポリン、第3世代セファロスポリン、第4世代セファロスポリン） ・世界のセファロスポリン市場予測2012-2027：種類別（第1世代セファロスポリン、第2世代セファロスポリン、第3世代セファロスポリン、第4世代セファロスポリン） ・世界のセファロスポリン市場規模2016-2021：用途別（経口、注射） ・世界のセファロスポリン市場予測2012-2027：用途別（経口、注射） ・セファロスポリンのアメリカ市場規模と予測2016-2021 ・セファロスポリンのヨーロッパ市場規模と予測2016-2021 ・セファロスポリンの中国市場規模と予測2016-2021 ・セファロスポリンの日本市場規模と予測2016-2021 ・セファロスポリンの東南アジア市場規模と予測2016-2021 ・セファロスポリンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm） ・セファロスポリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・セファロスポリンの市場動向・機会・課題 ・調査の結論 |
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016. China is the largest supplier of Cephalosporin, with a production market share nearly 43% in 2016. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22.3% in 2016. Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Cephalosporin Market
The global Cephalosporin market was valued at US$ 3988.7 in 2020 and will reach US$ 4465.6 million by the end of 2027, growing at a CAGR of 1.9% during 2022-2027.
Global Cephalosporin Scope and Market Size
The global Cephalosporin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cephalosporin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Segment by Application
Oral
Injection
The Cephalosporin market is analysed and market size information is provided by regions (countries). Segment by Application, the Cephalosporin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
1 Cephalosporin Market Overview
1.1 Cephalosporin Product Scope
1.2 Cephalosporin Segment by Type
1.2.1 Global Cephalosporin Sales by Type (2016 & 2021 & 2027)
1.2.2 First Generation Cephalosporin
1.2.3 Second Generation Cephalosporin
1.2.4 Third Generation Cephalosporin
1.2.5 Fourth Generation Cephalosporin
1.3 Cephalosporin Segment by Application
1.3.1 Global Cephalosporin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oral
1.3.3 Injection
1.4 Cephalosporin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Cephalosporin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Cephalosporin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Cephalosporin Price Trends (2016-2027)
2 Cephalosporin Estimates and Forecasts by Region
2.1 Global Cephalosporin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Cephalosporin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Cephalosporin Sales Market Share by Region (2016-2021)
2.2.2 Global Cephalosporin Revenue Market Share by Region (2016-2021)
2.3 Global Cephalosporin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Cephalosporin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Cephalosporin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Cephalosporin Estimates and Projections (2016-2027)
2.4.2 Europe Cephalosporin Estimates and Projections (2016-2027)
2.4.3 China Cephalosporin Estimates and Projections (2016-2027)
2.4.4 Japan Cephalosporin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Cephalosporin Estimates and Projections (2016-2027)
2.4.6 India Cephalosporin Estimates and Projections (2016-2027)
3 Global Cephalosporin Competition Landscape by Players
3.1 Global Top Cephalosporin Players by Sales (2016-2021)
3.2 Global Top Cephalosporin Players by Revenue (2016-2021)
3.3 Global Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cephalosporin as of 2020)
3.4 Global Cephalosporin Average Price by Company (2016-2021)
3.5 Manufacturers Cephalosporin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Cephalosporin Market Size by Type
4.1 Global Cephalosporin Historic Market Review by Type (2016-2021)
4.1.1 Global Cephalosporin Sales Market Share by Type (2016-2021)
4.1.2 Global Cephalosporin Revenue Market Share by Type (2016-2021)
4.1.3 Global Cephalosporin Price by Type (2016-2021)
4.2 Global Cephalosporin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Cephalosporin Sales Forecast by Type (2022-2027)
4.2.2 Global Cephalosporin Revenue Forecast by Type (2022-2027)
4.2.3 Global Cephalosporin Price Forecast by Type (2022-2027)
5 Global Cephalosporin Market Size by Application
5.1 Global Cephalosporin Historic Market Review by Application (2016-2021)
5.1.1 Global Cephalosporin Sales Market Share by Application (2016-2021)
5.1.2 Global Cephalosporin Revenue Market Share by Application (2016-2021)
5.1.3 Global Cephalosporin Price by Application (2016-2021)
5.2 Global Cephalosporin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Cephalosporin Sales Forecast by Application (2022-2027)
5.2.2 Global Cephalosporin Revenue Forecast by Application (2022-2027)
5.2.3 Global Cephalosporin Price Forecast by Application (2022-2027)
6 North America Cephalosporin Market Facts & Figures
6.1 North America Cephalosporin Sales by Company
6.1.1 North America Cephalosporin Sales by Company (2016-2021)
6.1.2 North America Cephalosporin Revenue by Company (2016-2021)
6.2 North America Cephalosporin Sales Breakdown by Type
6.2.1 North America Cephalosporin Sales Breakdown by Type (2016-2021)
6.2.2 North America Cephalosporin Sales Breakdown by Type (2022-2027)
6.3 North America Cephalosporin Sales Breakdown by Application
6.3.1 North America Cephalosporin Sales Breakdown by Application (2016-2021)
6.3.2 North America Cephalosporin Sales Breakdown by Application (2022-2027)
7 Europe Cephalosporin Market Facts & Figures
7.1 Europe Cephalosporin Sales by Company
7.1.1 Europe Cephalosporin Sales by Company (2016-2021)
7.1.2 Europe Cephalosporin Revenue by Company (2016-2021)
7.2 Europe Cephalosporin Sales Breakdown by Type
7.2.1 Europe Cephalosporin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Cephalosporin Sales Breakdown by Type (2022-2027)
7.3 Europe Cephalosporin Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Cephalosporin Market Facts & Figures
8.1 China Cephalosporin Sales by Company
8.1.1 China Cephalosporin Sales by Company (2016-2021)
8.1.2 China Cephalosporin Revenue by Company (2016-2021)
8.2 China Cephalosporin Sales Breakdown by Type
8.2.1 China Cephalosporin Sales Breakdown by Type (2016-2021)
8.2.2 China Cephalosporin Sales Breakdown by Type (2022-2027)
8.3 China Cephalosporin Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Cephalosporin Market Facts & Figures
9.1 Japan Cephalosporin Sales by Company
9.1.1 Japan Cephalosporin Sales by Company (2016-2021)
9.1.2 Japan Cephalosporin Revenue by Company (2016-2021)
9.2 Japan Cephalosporin Sales Breakdown by Type
9.2.1 Japan Cephalosporin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Cephalosporin Sales Breakdown by Type (2022-2027)
9.3 Japan Cephalosporin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Cephalosporin Market Facts & Figures
10.1 Southeast Asia Cephalosporin Sales by Company
10.1.1 Southeast Asia Cephalosporin Sales by Company (2016-2021)
10.1.2 Southeast Asia Cephalosporin Revenue by Company (2016-2021)
10.2 Southeast Asia Cephalosporin Sales Breakdown by Type
10.2.1 Southeast Asia Cephalosporin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Cephalosporin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Cephalosporin Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Cephalosporin Market Facts & Figures
11.1 India Cephalosporin Sales by Company
11.1.1 India Cephalosporin Sales by Company (2016-2021)
11.1.2 India Cephalosporin Revenue by Company (2016-2021)
11.2 India Cephalosporin Sales Breakdown by Type
11.2.1 India Cephalosporin Sales Breakdown by Type (2016-2021)
11.2.2 India Cephalosporin Sales Breakdown by Type (2022-2027)
11.3 India Cephalosporin Sales Breakdown by Application
11.3.1 India Cephalosporin Sales Breakdown by Application (2016-2021)
11.3.2 India Cephalosporin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Cephalosporin Business
12.1 Union Chempharma
12.1.1 Union Chempharma Corporation Information
12.1.2 Union Chempharma Business Overview
12.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Union Chempharma Cephalosporin Products Offered
12.1.5 Union Chempharma Recent Development
12.2 NCPC
12.2.1 NCPC Corporation Information
12.2.2 NCPC Business Overview
12.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NCPC Cephalosporin Products Offered
12.2.5 NCPC Recent Development
12.3 Qilu Antibiotics
12.3.1 Qilu Antibiotics Corporation Information
12.3.2 Qilu Antibiotics Business Overview
12.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Qilu Antibiotics Cephalosporin Products Offered
12.3.5 Qilu Antibiotics Recent Development
12.4 Lupin Pharmaceuticals
12.4.1 Lupin Pharmaceuticals Corporation Information
12.4.2 Lupin Pharmaceuticals Business Overview
12.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lupin Pharmaceuticals Cephalosporin Products Offered
12.4.5 Lupin Pharmaceuticals Recent Development
12.5 Hospira
12.5.1 Hospira Corporation Information
12.5.2 Hospira Business Overview
12.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hospira Cephalosporin Products Offered
12.5.5 Hospira Recent Development
12.6 Dhanuka Laboratories
12.6.1 Dhanuka Laboratories Corporation Information
12.6.2 Dhanuka Laboratories Business Overview
12.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dhanuka Laboratories Cephalosporin Products Offered
12.6.5 Dhanuka Laboratories Recent Development
12.7 Fukang
12.7.1 Fukang Corporation Information
12.7.2 Fukang Business Overview
12.7.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Fukang Cephalosporin Products Offered
12.7.5 Fukang Recent Development
12.8 Dongying Pharmaceutical
12.8.1 Dongying Pharmaceutical Corporation Information
12.8.2 Dongying Pharmaceutical Business Overview
12.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dongying Pharmaceutical Cephalosporin Products Offered
12.8.5 Dongying Pharmaceutical Recent Development
12.9 Alkem
12.9.1 Alkem Corporation Information
12.9.2 Alkem Business Overview
12.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Alkem Cephalosporin Products Offered
12.9.5 Alkem Recent Development
12.10 SALUBRIS
12.10.1 SALUBRIS Corporation Information
12.10.2 SALUBRIS Business Overview
12.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 SALUBRIS Cephalosporin Products Offered
12.10.5 SALUBRIS Recent Development
12.11 LIVZON
12.11.1 LIVZON Corporation Information
12.11.2 LIVZON Business Overview
12.11.3 LIVZON Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 LIVZON Cephalosporin Products Offered
12.11.5 LIVZON Recent Development
12.12 Hetero Drugs
12.12.1 Hetero Drugs Corporation Information
12.12.2 Hetero Drugs Business Overview
12.12.3 Hetero Drugs Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hetero Drugs Cephalosporin Products Offered
12.12.5 Hetero Drugs Recent Development
12.13 CSPC
12.13.1 CSPC Corporation Information
12.13.2 CSPC Business Overview
12.13.3 CSPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CSPC Cephalosporin Products Offered
12.13.5 CSPC Recent Development
12.14 TEVA
12.14.1 TEVA Corporation Information
12.14.2 TEVA Business Overview
12.14.3 TEVA Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 TEVA Cephalosporin Products Offered
12.14.5 TEVA Recent Development
12.15 Orchid Pharma
12.15.1 Orchid Pharma Corporation Information
12.15.2 Orchid Pharma Business Overview
12.15.3 Orchid Pharma Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Orchid Pharma Cephalosporin Products Offered
12.15.5 Orchid Pharma Recent Development
12.16 Taj Pharmaceuticals
12.16.1 Taj Pharmaceuticals Corporation Information
12.16.2 Taj Pharmaceuticals Business Overview
12.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Taj Pharmaceuticals Cephalosporin Products Offered
12.16.5 Taj Pharmaceuticals Recent Development
12.17 Covalent Laboratories
12.17.1 Covalent Laboratories Corporation Information
12.17.2 Covalent Laboratories Business Overview
12.17.3 Covalent Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Covalent Laboratories Cephalosporin Products Offered
12.17.5 Covalent Laboratories Recent Development
12.18 United Laboratories
12.18.1 United Laboratories Corporation Information
12.18.2 United Laboratories Business Overview
12.18.3 United Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.18.4 United Laboratories Cephalosporin Products Offered
12.18.5 United Laboratories Recent Development
12.19 Aurobindo
12.19.1 Aurobindo Corporation Information
12.19.2 Aurobindo Business Overview
12.19.3 Aurobindo Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Aurobindo Cephalosporin Products Offered
12.19.5 Aurobindo Recent Development
12.20 Wockhardt
12.20.1 Wockhardt Corporation Information
12.20.2 Wockhardt Business Overview
12.20.3 Wockhardt Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Wockhardt Cephalosporin Products Offered
12.20.5 Wockhardt Recent Development
12.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Business Overview
12.21.3 LKPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.21.4 LKPC Cephalosporin Products Offered
12.21.5 LKPC Recent Development
12.22 HPGC
12.22.1 HPGC Corporation Information
12.22.2 HPGC Business Overview
12.22.3 HPGC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.22.4 HPGC Cephalosporin Products Offered
12.22.5 HPGC Recent Development
12.23 Huafangpharm
12.23.1 Huafangpharm Corporation Information
12.23.2 Huafangpharm Business Overview
12.23.3 Huafangpharm Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Huafangpharm Cephalosporin Products Offered
12.23.5 Huafangpharm Recent Development
13 Cephalosporin Manufacturing Cost Analysis
13.1 Cephalosporin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cephalosporin
13.4 Cephalosporin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cephalosporin Distributors List
14.3 Cephalosporin Customers
15 Market Dynamics
15.1 Cephalosporin Market Trends
15.2 Cephalosporin Drivers
15.3 Cephalosporin Market Challenges
15.4 Cephalosporin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cephalosporin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Cephalosporin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Cephalosporin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Cephalosporin Sales (MT) by Region (2016-2021)
Table 5. Global Cephalosporin Sales Market Share by Region (2016-2021)
Table 6. Global Cephalosporin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Cephalosporin Revenue Share by Region (2016-2021)
Table 8. Global Cephalosporin Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Cephalosporin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Cephalosporin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Cephalosporin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Cephalosporin Sales (MT) of Key Companies (2016-2021)
Table 13. Global Cephalosporin Sales Share by Company (2016-2021)
Table 14. Global Cephalosporin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Cephalosporin Revenue Share by Company (2016-2021)
Table 16. Global Cephalosporin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2020)
Table 17. Global Cephalosporin Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Cephalosporin Manufacturing Sites and Area Served
Table 19. Manufacturers Cephalosporin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Cephalosporin Sales (MT) by Type (2016-2021)
Table 22. Global Cephalosporin Sales Share by Type (2016-2021)
Table 23. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Cephalosporin Price (USD/Kg) by Type (2016-2021)
Table 25. Global Cephalosporin Sales Share by Type (2022-2027)
Table 26. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Cephalosporin Revenue Share by Type (2022-2027)
Table 28. Global Cephalosporin Price (USD/Kg) by Type (2022-2027)
Table 29. Global Cephalosporin Sales (MT) by Application (2016-2021)
Table 30. Global Cephalosporin Sales Share by Application (2016-2021)
Table 31. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Cephalosporin Price (USD/Kg) by Application (2016-2021)
Table 33. Global Cephalosporin Sales (MT) by Application (2022-2027)
Table 34. Global Cephalosporin Sales Share by Application (2022-2027)
Table 35. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Cephalosporin Revenue Share by Application (2022-2027)
Table 37. Global Cephalosporin Price (USD/Kg) by Application (2022-2027)
Table 38. North America Cephalosporin Sales (MT) by Company (2016-2021)
Table 39. North America Cephalosporin Sales Market Share by Company (2016-2021)
Table 40. North America Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Cephalosporin Revenue Market Share by Company (2016-2021)
Table 42. North America Cephalosporin Sales by Type (2016-2021) & (MT)
Table 43. North America Cephalosporin Sales Market Share by Type (2016-2021)
Table 44. North America Cephalosporin Sales by Type (2022-2027) & (MT)
Table 45. North America Cephalosporin Sales Market Share by Type (2022-2027)
Table 46. North America Cephalosporin Sales by Application (2016-2021) & (MT)
Table 47. North America Cephalosporin Sales Market Share by Application (2016-2021)
Table 48. North America Cephalosporin Sales by Application (2022-2027) & (MT)
Table 49. North America Cephalosporin Sales Market Share by Application (2022-2027)
Table 50. Europe Cephalosporin Sales (MT) by Company (2016-2021)
Table 51. Europe Cephalosporin Sales Market Share by Company (2016-2021)
Table 52. Europe Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Cephalosporin Revenue Market Share by Company (2016-2021)
Table 54. Europe Cephalosporin Sales by Type (2016-2021) & (MT)
Table 55. Europe Cephalosporin Sales Market Share by Type (2016-2021)
Table 56. Europe Cephalosporin Sales by Type (2022-2027) & (MT)
Table 57. Europe Cephalosporin Sales Market Share by Type (2022-2027)
Table 58. Europe Cephalosporin Sales by Application (2016-2021) & (MT)
Table 59. Europe Cephalosporin Sales Market Share by Application (2016-2021)
Table 60. Europe Cephalosporin Sales by Application (2022-2027) & (MT)
Table 61. Europe Cephalosporin Sales Market Share by Application (2022-2027)
Table 62. China Cephalosporin Sales (MT) by Company (2016-2021)
Table 63. China Cephalosporin Sales Market Share by Company (2016-2021)
Table 64. China Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Cephalosporin Revenue Market Share by Company (2016-2021)
Table 66. China Cephalosporin Sales by Type (2016-2021) & (MT)
Table 67. China Cephalosporin Sales Market Share by Type (2016-2021)
Table 68. China Cephalosporin Sales by Type (2022-2027) & (MT)
Table 69. China Cephalosporin Sales Market Share by Type (2022-2027)
Table 70. China Cephalosporin Sales by Application (2016-2021) & (MT)
Table 71. China Cephalosporin Sales Market Share by Application (2016-2021)
Table 72. China Cephalosporin Sales by Application (2022-2027) & (MT)
Table 73. China Cephalosporin Sales Market Share by Application (2022-2027)
Table 74. Japan Cephalosporin Sales (MT) by Company (2016-2021)
Table 75. Japan Cephalosporin Sales Market Share by Company (2016-2021)
Table 76. Japan Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Cephalosporin Revenue Market Share by Company (2016-2021)
Table 78. Japan Cephalosporin Sales by Type (2016-2021) & (MT)
Table 79. Japan Cephalosporin Sales Market Share by Type (2016-2021)
Table 80. Japan Cephalosporin Sales by Type (2022-2027) & (MT)
Table 81. Japan Cephalosporin Sales Market Share by Type (2022-2027)
Table 82. Japan Cephalosporin Sales by Application (2016-2021) & (MT)
Table 83. Japan Cephalosporin Sales Market Share by Application (2016-2021)
Table 84. Japan Cephalosporin Sales by Application (2022-2027) & (MT)
Table 85. Japan Cephalosporin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Cephalosporin Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Cephalosporin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Cephalosporin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Cephalosporin Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Cephalosporin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Cephalosporin Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Cephalosporin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Cephalosporin Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Cephalosporin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Cephalosporin Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Cephalosporin Sales Market Share by Application (2022-2027)
Table 98. India Cephalosporin Sales (MT) by Company (2016-2021)
Table 99. India Cephalosporin Sales Market Share by Company (2016-2021)
Table 100. India Cephalosporin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Cephalosporin Revenue Market Share by Company (2016-2021)
Table 102. India Cephalosporin Sales by Type (2016-2021) & (MT)
Table 103. India Cephalosporin Sales Market Share by Type (2016-2021)
Table 104. India Cephalosporin Sales by Type (2022-2027) & (MT)
Table 105. India Cephalosporin Sales Market Share by Type (2022-2027)
Table 106. India Cephalosporin Sales by Application (2016-2021) & (MT)
Table 107. India Cephalosporin Sales Market Share by Application (2016-2021)
Table 108. India Cephalosporin Sales by Application (2022-2027) & (MT)
Table 109. India Cephalosporin Sales Market Share by Application (2022-2027)
Table 110. Union Chempharma Corporation Information
Table 111. Union Chempharma Description and Business Overview
Table 112. Union Chempharma Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Union Chempharma Cephalosporin Product
Table 114. Union Chempharma Recent Development
Table 115. NCPC Corporation Information
Table 116. NCPC Description and Business Overview
Table 117. NCPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. NCPC Cephalosporin Product
Table 119. NCPC Recent Development
Table 120. Qilu Antibiotics Corporation Information
Table 121. Qilu Antibiotics Description and Business Overview
Table 122. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Qilu Antibiotics Cephalosporin Product
Table 124. Qilu Antibiotics Recent Development
Table 125. Lupin Pharmaceuticals Corporation Information
Table 126. Lupin Pharmaceuticals Description and Business Overview
Table 127. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Lupin Pharmaceuticals Cephalosporin Product
Table 129. Lupin Pharmaceuticals Recent Development
Table 130. Hospira Corporation Information
Table 131. Hospira Description and Business Overview
Table 132. Hospira Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Hospira Cephalosporin Product
Table 134. Hospira Recent Development
Table 135. Dhanuka Laboratories Corporation Information
Table 136. Dhanuka Laboratories Description and Business Overview
Table 137. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Dhanuka Laboratories Cephalosporin Product
Table 139. Dhanuka Laboratories Recent Development
Table 140. Fukang Corporation Information
Table 141. Fukang Description and Business Overview
Table 142. Fukang Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Fukang Cephalosporin Product
Table 144. Fukang Recent Development
Table 145. Dongying Pharmaceutical Corporation Information
Table 146. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Dongying Pharmaceutical Description and Business Overview
Table 148. Dongying Pharmaceutical Cephalosporin Product
Table 149. Dongying Pharmaceutical Recent Development
Table 150. Alkem Corporation Information
Table 151. Alkem Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Alkem Description and Business Overview
Table 153. Alkem Cephalosporin Product
Table 154. Alkem Recent Development
Table 155. SALUBRIS Corporation Information
Table 156. SALUBRIS Description and Business Overview
Table 157. SALUBRIS Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. SALUBRIS Cephalosporin Product
Table 159. SALUBRIS Recent Development
Table 160. LIVZON Corporation Information
Table 161. LIVZON Description and Business Overview
Table 162. LIVZON Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. LIVZON Cephalosporin Product
Table 164. LIVZON Recent Development
Table 165. Hetero Drugs Corporation Information
Table 166. Hetero Drugs Description and Business Overview
Table 167. Hetero Drugs Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Hetero Drugs Cephalosporin Product
Table 169. Hetero Drugs Recent Development
Table 170. CSPC Corporation Information
Table 171. CSPC Description and Business Overview
Table 172. CSPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. CSPC Cephalosporin Product
Table 174. CSPC Recent Development
Table 175. TEVA Corporation Information
Table 176. TEVA Description and Business Overview
Table 177. TEVA Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 178. TEVA Cephalosporin Product
Table 179. TEVA Recent Development
Table 180. Orchid Pharma Corporation Information
Table 181. Orchid Pharma Description and Business Overview
Table 182. Orchid Pharma Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 183. Orchid Pharma Cephalosporin Product
Table 184. Orchid Pharma Recent Development
Table 185. Taj Pharmaceuticals Corporation Information
Table 186. Taj Pharmaceuticals Description and Business Overview
Table 187. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 188. Taj Pharmaceuticals Cephalosporin Product
Table 189. Taj Pharmaceuticals Recent Development
Table 190. Covalent Laboratories Corporation Information
Table 191. Covalent Laboratories Description and Business Overview
Table 192. Covalent Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 193. Covalent Laboratories Cephalosporin Product
Table 194. Covalent Laboratories Recent Development
Table 195. United Laboratories Corporation Information
Table 196. United Laboratories Description and Business Overview
Table 197. United Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 198. United Laboratories Cephalosporin Product
Table 199. United Laboratories Recent Development
Table 200. Aurobindo Corporation Information
Table 201. Aurobindo Description and Business Overview
Table 202. Aurobindo Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 203. Aurobindo Cephalosporin Product
Table 204. Aurobindo Recent Development
Table 205. Wockhardt Corporation Information
Table 206. Wockhardt Description and Business Overview
Table 207. Wockhardt Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 208. Wockhardt Cephalosporin Product
Table 209. Wockhardt Recent Development
Table 210. LKPC Corporation Information
Table 211. LKPC Description and Business Overview
Table 212. LKPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 213. LKPC Cephalosporin Product
Table 214. LKPC Recent Development
Table 215. HPGC Corporation Information
Table 216. HPGC Description and Business Overview
Table 217. HPGC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 218. HPGC Cephalosporin Product
Table 219. HPGC Recent Development
Table 220. Huafangpharm Corporation Information
Table 221. Huafangpharm Description and Business Overview
Table 222. Huafangpharm Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 223. Huafangpharm Cephalosporin Product
Table 224. Huafangpharm Recent Development
Table 225. Production Base and Market Concentration Rate of Raw Material
Table 226. Key Suppliers of Raw Materials
Table 227. Cephalosporin Distributors List
Table 228. Cephalosporin Customers List
Table 229. Cephalosporin Market Trends
Table 230. Cephalosporin Market Drivers
Table 231. Cephalosporin Market Challenges
Table 232. Cephalosporin Market Restraints
Table 233. Research Programs/Design for This Report
Table 234. Key Data Information from Secondary Sources
Table 235. Key Data Information from Primary Sources
List of Figures
Figure 1. Cephalosporin Product Picture
Figure 2. Global Cephalosporin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cephalosporin Sales Market Share by Application in 2021 & 2027
Figure 6. Oral Examples
Figure 7. Injection Examples
Figure 8. Global Cephalosporin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Cephalosporin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Cephalosporin Sales (MT) Growth Rate (2016-2027)
Figure 11. Global Cephalosporin Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Cephalosporin Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Cephalosporin Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Cephalosporin Sales (MT) Growth Rate (2016-2027)
Figure 16. Europe Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Cephalosporin Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Cephalosporin Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Cephalosporin Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Cephalosporin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Cephalosporin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Cephalosporin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Cephalosporin Players Market Share by Revenue in Cephalosporin: 2016 & 2020
Figure 27. Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Cephalosporin Revenue Share by Type (2016-2021)
Figure 29. Global Cephalosporin Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Cephalosporin Revenue Share by Application (2016-2021)
Figure 31. Global Cephalosporin Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Cephalosporin Sales Market Share by Type in 2020
Figure 33. North America Cephalosporin Sales Market Share by Application in 2020
Figure 34. Europe Cephalosporin Sales Market Share by Type in 2020
Figure 35. Europe Cephalosporin Sales Market Share by Application in 2020
Figure 36. China Cephalosporin Sales Market Share by Type in 2020
Figure 37. China Cephalosporin Sales Market Share by Application in 2020
Figure 38. Japan Cephalosporin Sales Market Share by Type in 2020
Figure 39. Japan Cephalosporin Sales Market Share by Application in 2020
Figure 40. Southeast Asia Cephalosporin Sales Market Share by Type in 2020
Figure 41. Southeast Asia Cephalosporin Sales Market Share by Application in 2020
Figure 42. India Cephalosporin Sales Market Share by Type in 2020
Figure 43. India Cephalosporin Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Cephalosporin
Figure 46. Manufacturing Process Analysis of Cephalosporin
Figure 47. Cephalosporin Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の次世代遠隔医療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next Generation Telehealth Market The global Next Generation Telehealth market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …- 次世代メモリのグローバル市場2021 This report studies the Next Generation Memory market. The Next Generation Memory is cost effective and provides faster memory solutions whereas older memory technologies have limitations because of their outdated architecture and higher power consumption. The Next Generation Memory provides high da…
- 世界の移動式発電機レンタル市場規模・現状・予測（2021年-2027年） Mobile Power Generation Equipment Rentals service for individuals and enterprises. Market Analysis and Insights: Global Mobile Power Generation Equipment Rentals Market The global Mobile Power Generation Equipment Rentals market size is projected to reach US$ XX million by 2027, from US$ XX million …
- 世界の第三世代シーケンシング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-generation Sequencing Technology Market The global Third-generation Sequencing Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界の末梢神経修復＆再生市場規模・現状・予測（2021年-2027年） Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage o…